Related Image: American Chemical Society's Weekly PressPac -- June 3, 2009 |
(Date:11/20/2009)..., SAN DIEGO, Nov. 20 Veridiam (ww...in the mid-size company category at the 2009 Workp...y the San Diego Society for Human Resources Manage...n resources practices. ,, Veridiam was one of n...nominated companies, honored at the recent awards ...
(Date:11/20/2009)... , STOCKHOLM, November 20 ... European Investment Fund (EIF) has entered into a...investment fund will be,managed by Karolinska Deve...lio of early-stage pharmaceutical and medical tech...Euros in the co-investment fund. The agreement,rep...
(Date:11/20/2009)... METTLER TOLEDO recently announce...webinar, “The Role of Process Analytical Tec...ring” on December 1, 2009. , ... The Role of Process Analytical Technology (PAT) i...n December 1, Process Analytical Technology (PAT) ...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Omer...audited financial results for the third quarter en... September 30, 2009, Omeros reported a net loss of...a net loss of $7.4 million, or $2.54 per share, fo...ed September 30, 2009, the Company reported a net ...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8...research may have come up with an explanation as t...d rocks. This explanation could turn out to be the...production techniques with the intent of increasin...arch group at the Nano-Science Center, part of the...n has investigated drill cores collected from Nort...
..., May 11 Sanofi-aventis U.S. announced today that...ma plc the U.S. commercial rights to Oforta(TM) (f... B-cell chronic lymphocytic leukemia (CLL) drug. ... for use as a second-line therapy to treat adults ...to add Oforta to our existing oncology portfolio, ...
...May 11 Pharmasset, Inc. (Nasdaq: VRUS ), a clin...covering, developing, and commercializing novel dr...results and operational highlights for the fiscal ...ults , , Revenues were $1.9 million during the q...on for the quarter ended March 31, 2008 and reflec...
Other Biology Technology:New Danish research shows how oil gets stuck underground 2Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment 2Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 5Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 6Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 7Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 85X StabilCoat Immunoassay Stabilizer from SurModics, Inc.
...llow crystalline solid. PROTECT FROM LIGHT. Useful...response data are not required. Purity: ≥98% b...us systems, preparation of a 10 mM stock in DMSO i... can be added to H 2 O with rapid mixing (e.g. 10 ...
Mouse Anti-Fatty Acid Binding Protein (FABP) Antibody, TRITC (Rhodamine) Conjugated from HyTest Ltd.
Mouse Anti-Rhodopsin Monoclonal Antibody, Unconjugated, Clone RET-P1 from GeneTex
Biology Products: